Nuclear factor-κB (NF-κB)/Rel proteins include NF-κB2 p52/p100, NF-κB1 p50/p105, c-Rel, RelA/p65, and RelB.These proteins perform as two-component transcription factors that control gene expression and have an impact on a variety of biological processes, such as innate and acquired immunity, inflammation, stress responses, B-cell development, and lymphoid organogenesis.The immune system's reaction to infection is significantly regulated by NF-B. In addition, the etiology of chronic inflammatory illnesses such inflammatory bowel disease, rheumatoid arthritis, and asthma is influenced by the activation of the NF-B pathway. Septic shock, autoimmune and inflammatory disorders, viral infections, and poor immunological development have all been connected to faulty NF-B regulation.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V84593 | biKEAP1 | ||
|
V82274 | Bisphenol A-d16 (bisphenol A-d16) | 96210-87-6 | Bisphenol A-d16 is the deuterium labelled form of Bisphenol A. |
|
V82273 | Bisphenol A-d4-1 (bisphenol A-d4-1) | 347841-41-2 | Bisphenol A-d4-1 is the deuterated form of Bisphenol A. |
|
V82272 | Bisphenol A-d6 (bisphenol A d6) | 86588-58-1 | Bisphenol A-d6 is the deuterium labelled form of Bisphenol A. |
|
V82276 | Bisphenol A-d8 (bisphenol A-d8) | 92739-58-7 | Bisphenol A-d8 is a phenolic organic synthetic compound extensively used in the production of polycarbonate plastics and epoxy resins. |
|
V17405 | C25-140 | 1358099-18-9 | C25-140 (C-25140;C25140) is a novel, first-in-class and potent inhibitor of RING-E3 ligase (TRAF6) / E2 enzyme (Ubc13) protein-protein interaction (PPI) with potential use forautoimmune and chronic inflammatory diseases. |
|
V0766 | Caffeic Acid Phenethyl Ester | 104594-70-9 | Caffeic acid phenethyl ester (also called CAPE; BAF-IN-C09; 2-Phenylethyl Caffeate; β-Phenylethyl Caffeate), a naturally occuring compound isolated fromhoneybee hive propolis, is potent and specific inhibitor of NF-κB activation with antioxidant, anticancer, immunomodulatory and antiinflammatory activities. |
|
V82254 | Cannabidiorcol (O-1821; CBD-C1) | 35482-50-9 | Cannabidiorcol (CBDO, CBD-C1, O-1821) an analogue of cannabidiol with its pentyl side chain shortened to a methyl group. |
|
V83482 | CAY10512 | 139141-12-1 | |
|
V3172 | CBL0137 | 1197996-80-7 | CBL0137 (formerly known as Curaxin 137 or CBL-0137) is an inhibitor of the histone chaperone,FACT (facilitates chromatin transcription complex). |
|
V17766 | CD40-TRAF6 inhibitor | 433249-94-6 | CD40-TRAF6 inhibitor (TRAF-STOP inhibitor 6877002) is a novel and potent inhibitor of CD40-TRAF6 protein protein interaction with the potential for treatingatherosclerosis. |
|
V84712 | Chebulanin | 166833-80-3 | |
|
V82284 | cis-Vitamin K1 (cis-Phylloquinone; cis-Phytomenadione) | 16033-41-3 | Cis-Vitamin K1 is an endogenously produced metabolite of Vitamin K. |
|
V1935 | CORM-3 | 475473-26-8 | CORM-3 is a water-soluble carbon monoxide (CO)-releasing molecule with potent anti-inflammatory and cardioprotective activity byattenuatingNF-κB p65 nuclear translocation, reducing ROS generation and enhancing intracellular glutathione and superoxide dismutase levels. |
|
V70207 | Cryptanoside A | 98570-81-1 | Cryptanoside A is a cardiac glycoside epoxide that can be extracted from the stems of Cryptolepis dubia. |
|
V17235 | Curcumenol | 19431-84-6 | Curcumenol is a potent CYP3A4 inhibitor (antagonist) with IC50 of 12.6 μM. |
|
V82283 | D-Ribofuranose (D-Ribose) | 613-83-2 | D-Ribofuranose (D-Ribose) is an endogenously produced metabolite present in cerebrospinal fluid and has been used to study ribose-5-phosphate isomerase deficiency and medium-chain acylcobalt A dehydrogenase deficiency. |
|
V60088 | Damascenone | 23696-85-7 | Damascenone is an active compound of Epipremnum pinnatum which has anti-inflammatory properties. E-isomer- and Z-isomer-Damascenone combine to form the compound known as damascenone. |
|
V83688 | DC-SX029 | 300713-88-6 | |
|
V40050 | DCZ0415 | 2242470-43-3 | DCZ0415 (DCZ-0415; DCZ 0415) is a novel and highly potent TRIP13 inhibitor that is able to impair nonhomologous end joining repair and inhibits NF-κB activity. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
